Patents by Inventor Joshua M. Pearlman

Joshua M. Pearlman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using CRCA-1 as a stomach and esophageal cancer marker
    Patent number: 7829276
    Abstract: Screening and diagnostic reagents, kits and methods for stomach or esophageal cancer are disclosed. Compounds, compositions and methods of treating patients with stomach or esophageal cancer and for imaging stomach or esophageal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as drugs, gene therapeutics and antisense compounds to stomach or esophageal cells are disclosed. Vaccines compositions and methods of for treating and preventing stomach or esophageal cancer are disclosed.
    Type: Grant
    Filed: September 18, 2001
    Date of Patent: November 9, 2010
    Assignee: Thomas Jefferson University
    Inventors: Scott A. Waldman, Joshua M. Pearlman, Michael T. Barber, Stephanie Schulz, Scott J. Parkinson, Scott Prawer
  • Compositions that specifically bind to colorectal cancer cells and methods of using the same
    Patent number: 7316902
    Abstract: A unique transcription product, CRCA-1, and alternative translation products generated therefrom, are disclosed. The transcript and its translation products are markers for colorectal cells. Screening and diagnostic reagents, kits and methods for metastasized colorectal cancer are disclosed ars are reagents, kits and methods for identifying adenocarcinomas as colorectal in origin. Compounds, compositions and methods of treating patients with metastasized colorectal cancer and for imaging metastasized colorectal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as gene therapeutics and antisense compounds to colorectal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastasized colorectal cancer are disclosed.
    Type: Grant
    Filed: September 5, 2003
    Date of Patent: January 8, 2008
    Assignee: Thomas Jefferson University
    Inventors: Scott A. Waldman, Joshua M. Pearlman, Michael T. Barber, Stephanie Schulz, Scott J. Parkinson
  • Compositions that specifically bind to colorectal cancer cells and methods of using the same
    Patent number: 7135333
    Abstract: A unique transcription product, CRCA-1, and alternative translation products generated therefrom, are disclosed. The transcript and its translation products are markers for colorectal cells. Screening and diagnostic reagents, kits and methods for metastasized colorectal cancer are disclosed as are reagents, kits and methods for identifying adenocarcinomas as colorectal in origin. Compounds, compositions and methods of treating patients with metastasized colorectal cancer and for imaging metastasized colorectal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as gene therapeutics and antisense compounds to colorectal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastasized colorectal cancer are disclosed.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: November 14, 2006
    Assignee: Thomas Jefferson University
    Inventors: Scott A. Waldman, Joshua M. Pearlman, Michael T. Barber, Stephanie Schulz, Scott J. Parkinson
  • Compositions that specifically bind to colorectal cancer cells and methods of using the same
    Publication number: 20040146954
    Abstract: A unique transcription product, CRCA-1, and alternative translation products generated thereform, are disclosed. The transcript and its translation products are markers for colorectal cells. Screening and diagnostic reagents, kits and methods for metastasized colorectal cancer are disclosed ars are reagents, kits and methods for identifying adenocarcinomas as colorectal in origin. Compounds, composotions and methods of treating patients with metastasized colorectal cancer and for imaging metastasized colorectal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as gene therapeutics and antisense compounds to colorectal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastasized colorectal cancer are disclosed.
    Type: Application
    Filed: September 5, 2003
    Publication date: July 29, 2004
    Applicant: Thomas Jefferson University
    Inventors: Scott A. Waldman, Joshua M. Pearlman, Michael T. Barber, Stephanie Schulz, Scott J. Parkinson
  • Compositions that specifically bind to colorectal cancer cells and methods of using the same
    Patent number: 6120995
    Abstract: A unique transcription product, CRCA-1, and alternative translation products generated thereform, are disclosed. The transcript and its translation products are markers for colorectal cells. Screening and diagnostic reagents, kits and methods for metastasized colorectal cancer are disclosed as are reagents, kits and methods for identifying adenocarcinomas as colorectal in origin. Compounds, compositions and methods of treating patients with metastasized colorectal cancer and for imaging metastasized colorectal tumors in vivo are disclosed. Compositions and methods for delivering active compounds such as gene therapeutics and antisense compounds to colorectal cells are disclosed. Vaccines compositions and methods of for treating and preventing metastasized colorectal cancer are disclosed.
    Type: Grant
    Filed: August 7, 1997
    Date of Patent: September 19, 2000
    Assignee: Thomas Jefferson University
    Inventors: Scott A. Waldman, Joshua M. Pearlman, Michael T. Barber, Stephanie Schulz, Scott J. Parkinson